DNOW Inc. Investors Offered Opportunity to Lead Securities Lawsuit
Rosen Law Firm is inviting DNOW Inc. investors to join a securities class action. The deadline for potential lead plaintiffs to act is October 2, 2026.

New York โ September 25, 2026 โ Rosen Law Firm, a global investor rights law firm, is notifying purchasers of DNOW Inc. common stock (NYSE: DNOW) who held shares as of the August 5, 2025 record date that they may have the opportunity to lead a securities class action lawsuit. The firm has already filed a complaint on behalf of investors who allege misleading statements and omissions by the company.
Investors who owned DNOW stock as of August 5, 2025, were entitled to vote at a special meeting held on September 9, 2025. The deadline for potential lead plaintiffs to move the court is October 2, 2026. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
The lawsuit alleges that DNOW Inc. and its executives made false or misleading statements and failed to disclose material information. Specifically, the complaint claims that defendants negligently understated the challenges associated with DNOW's merger with MRC Global Inc. due to material issues with MRC Global's new enterprise resource planning (ERP) system, which the defendants knew or should have known about.
As a result, the lawsuit asserts that DNOW's statements about its business, operations, and prospects were materially false and misleading and lacked a reasonable basis at all relevant times. When the true details entered the market, investors allegedly suffered damages. The firm urges investors seeking to join the class action or obtain further information to contact Rosen Law Firm.
Rosen Law Firm specializes in securities class actions and shareholder derivative litigation. The firm encourages investors to select counsel with a proven track record of success in leadership roles, noting its experience in recovering billions of dollars for investors in numerous securities class actions.